Astria Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
602
across all filing types
Latest filing
2026-02-17
Major Shareholding Noti…
Country
US
United States of America
Listing
US
ATXS
Astria Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for allergic and immunologic diseases. The company's mission is to provide life-changing treatments to patients and their families. Its lead product candidate, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein being developed as a potential long-acting, preventative treatment for Hereditary Angioedema (HAE). The company has reported positive initial proof-of-concept results from its ALPHA-STAR Phase 1b/2 clinical trial for STAR-0215. Astria Therapeutics is guided by patient needs to develop differentiated therapeutics that address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject) | 2026-02-09 | English | |
| SCHEDULE 13D/A Filing | 2026-01-28 | English | |
| 4 - ASTRIA THERAPEUTICS, INC. (0001454789) (Filer) | 2026-01-23 | English | |
| 25-NSE Filing | 2026-01-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 29885992 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29886031 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 18466762 | SCHEDULE 13D/A - Astria Therapeutics, Inc. (0001454789) (Subject) | 2026-02-09 | English | ||
| 29886027 | SCHEDULE 13D/A Filing | 2026-01-28 | English | ||
| 32892086 | 4 - ASTRIA THERAPEUTICS, INC. (0001454789) (Filer) | 2026-01-23 | English | ||
| 29886124 | 25-NSE Filing | 2026-01-23 | English | ||
| 29886077 | 4 Filing | 2026-01-23 | English | ||
| 29886063 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886048 | 4 Filing | 2026-01-23 | English | ||
| 29886039 | 4 Filing | 2026-01-23 | English | ||
| 29886034 | 8-K Filing | 2026-01-23 | English | ||
| 29886022 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886020 | S-8 POS Filing | 2026-01-23 | English | ||
| 29886001 | 4 Filing | 2026-01-23 | English | ||
| 29886000 | S-8 POS Filing | 2026-01-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Astria Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33001/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33001 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33001 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33001 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33001}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Astria Therapeutics, Inc. (id: 33001)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.